Alterity Therapeutics Limited - Sponsored ADR

ATHE Healthcare Biotechnology

Revenue growth for five consecutive years; insiders bought in the last twelve months.

2.62 0.10 −3.68%
Market cap
$52.0M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
2.15
Beneish M
30.19
Dividend safety
n/a
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17
Piotroski F-Score
— — — — — 4 2 2 3 4
P/E ratio
— — — — — 0.00 0.00 0.00 0.00 0.00
P/S ratio
— — — — — 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — — 2.15 (19.56) (7.37) (4.93) 3.78
P/FCF ratio
— — — — — 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— — — — — (3.25) (52.26) (16.67) (13.35) 4.19
Beneish M-Score
— — — — — 30.19 (10.82) (1.78) (3.24) (3.57)
P/Operating CF
— — — — — 0.00 0.00 0.00 0.00 0.00
P/B ratio
— — — — — 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
— — — — — 0.00 0.00 0.00 0.00 0.00
EV/Sales
— — — — — 0.00 0.00 0.00 0.00 0.00
EV/EBITDA
— — — — — 0.86 0.26 0.00 0.00 0.00
EV/Operating CF
— — — — — 1.73 0.31 0.49 1.11 1.06
EV/FCF
— — — — — 1.73 0.31 0.49 1.10 1.06
Quick Ratio
14.26 10.49 3.10 5.58 6.79 10.56 3.41 5.79 6.95 15.67
Current Ratio
14.52 12.98 3.54 6.17 7.07 10.92 3.62 5.98 7.06 15.88
Net Debt/EBITDA
1.32 1.67 0.55 0.91 1.99 1.89 0.71 1.17 1.97 3.31
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.21 0.01 0.25 0.15 0.11
Operating CF/Net income
0.96 0.94 0.66 1.45 0.96 1.13 0.70 1.13 0.76 0.78
Capex/Depreciation
0.00 0.00 (0.04) (0.07) (1.65) (0.14) (0.15) (0.24) (2.86) (1.30)
ROE
(56.26%) (43.10%) (102.77%) (45.24%) (38.44%) (82.99%) (108.60%) (72.60%) (42.26%) (27.93%)
ROA
(52.04%) (37.10%) (80.92%) (38.41%) (33.83%) (72.06%) (86.50%) (61.37%) (38.17%) (26.06%)
ROIC
(327.72%) (135.49%) (1,248.22%) (154.05%) (1,656.09%) (396.76%) 0.00% (358.62%) (574.31%) (229.92%)
Return on Tangible Assets
(54.84%) (28.69%) (139.64%) (60.75%) (36.26%) (50.27%) (187.91%) (74.37%) (51.40%) (31.84%)
Average Days of Receivables
0.00 0.00 0.00 0.00 0.00 346.52 160.15 348.40 345.85 351.17
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 272.62% 7,221.62% 256.60% 201.33% 180.67%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 153.97% 2,464.43% 85.15% 130.48% 135.48%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 41.83% (8.63%) 0.00% 0.00% 0.00%
Graham Net Nets
— — — — — 0.00 0.00 0.00 0.00 0.00
Graham Number
— — — — — 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— — — — — (0.17%) (0.23%) (1.10%) (39.46%) (108.07%)
Free Cash Flow Yield
— — — — — 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue per Share
0.00 0.00 0.00 0.00 0.00 1.19 0.06 3.53 2.90 2.67
Operating CF per Share
(0.87) (0.70) (1.36) (3.33) (2.23) (4.58) (4.25) (9.72) (5.44) (4.97)
Capex per Share
0.00 0.00 0.00 0.00 (0.02) 0.00 (0.01) 0.00 (0.05) (0.02)
Free Cash Flow per Share
(0.87) (0.70) (1.36) (3.33) (2.25) (4.58) (4.25) (9.73) (5.49) (4.99)
Cash per Share
1.44 2.01 1.36 2.62 6.30 7.43 4.14 10.03 13.27 18.54
Shareholders Equity per Share
1.65 2.58 1.49 3.80 6.42 8.05 3.22 11.54 14.01 20.07
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.65 2.58 1.49 3.80 6.42 8.05 3.22 11.54 14.01 20.07
Free Cash Flow
(15.29) (7.42) (8.27) (13.49) (9.02) (12.96) (6.34) (9.99) (4.89) (4.44)
Working Capital
28.96 27.42 8.96 15.26 25.63 22.73 4.78 11.83 12.41 17.84
Capital Expenditures
— — 0.00 0.00 (0.06) (0.01) (0.01) 0.00 (0.05) (0.02)
Net Current Asset Value
28.87 27.36 8.93 15.18 25.57 22.70 4.75 11.81 12.41 17.84
EV/EBIT
— — — — — 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— — 0.00 0.00 0.00 0.00 0.12 0.00 0.02 0.01
Price to Operating Income
— — — — — 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
392.00 36.20 4.58 1.65 0.53 2.41 2.85 0.61 0.31 0.69
Cash ROIC
(28.14%) (15.15%) (47.70%) (51.94%) (17.68%) (29.60%) (57.79%) (45.10%) (20.14%) (12.93%)
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 2.08 0.05 1.23 1.09 0.82
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
— — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
3.89 2.60 4.24 4.63 3.31 1.62 1.75 2.95 2.37 2.89
Average Payables
1.52 2.35 2.70 3.03 2.78 1.63 1.67 1.77 1.13 0.97
Average Assets
30.52 21.21 15.50 24.20 27.55 15.87 10.45 14.38 16.79 21.82
Average Common Equity
28.23 18.25 12.20 20.55 24.25 13.78 8.32 12.15 15.16 20.36

Fold the line items

Columns are period end dates